Glyco-engineered CHO cell lines producing alpha-1-antitrypsin and C1 esterase inhibitor with fully humanized N-glycosylation profiles
Article in Metabolic Engineering (December 2018)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective
Article in Clinical & Experimental Immunology (November 2015)
Recombinant Human-C1 Inhibitor Is Effective and Safe for Repeat Hereditary Angioedema Attacks
Article in The Journal of Allergy and Clinical Immunology In Practice (February 2015)